GENMAB A/S/S (GMXAY) News Today $21.98 -2.17 (-8.97%) As of 03/10/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Genmab A/S Navigates Global Economic and Geopolitical Challenges Amidst Market VolatilityFebruary 13, 2025 | msn.comGenmab A/S schedules annual general meetingFebruary 13, 2025 | msn.comLeerink raises Genmab stock rating to outperform, PT steady at $27February 13, 2025 | msn.comTruist maintains Buy on Genmab stock, price target at $50February 13, 2025 | msn.comGenmab upgraded to Neutral from Underperform at Exane BNP ParibasFebruary 11, 2025 | markets.businessinsider.comGenmab's SWOT analysis: antibody specialist's stock faces post-Darzalex challengeJanuary 30, 2025 | msn.comGenmab grants stock units and warrants to employeesJanuary 23, 2025 | msn.comGenmab reports 2024 net sales of Darzalex $11.67BJanuary 22, 2025 | markets.businessinsider.comGenmab reports 2024 DARZALEX net salesJanuary 22, 2025 | msn.comRBC Capital Keeps Their Buy Rating on Genmab A/S (0MGB)December 13, 2024 | markets.businessinsider.comGenmab’s Strong Performance and Strategic Positioning: A Buy Rating with $50 Price TargetOctober 16, 2024 | markets.businessinsider.comGM’s PowerBank home battery is now availableOctober 12, 2024 | msn.comGenmab A/S (GMAB): Among The Stocks With Biggest Upside Potential According to Hedge FundsOctober 9, 2024 | msn.comMoxie, which helps nurses launch medspas, raises a preemptive Series B from Lachy GroomSeptember 24, 2024 | techcrunch.comGenmab shares reiterate Buy rating on FDA approvalSeptember 22, 2024 | uk.investing.comStrong Financials and Pipeline Promise Affirm Buy Rating for Genmab A/SSeptember 20, 2024 | markets.businessinsider.comGenmab shares supported by strong Phase 1/2 data, Buy rating reiteratedSeptember 18, 2024 | uk.investing.comOptimistic Buy Rating for Genmab on Promising Acasunlimab Clinical Data and Future Growth PotentialSeptember 13, 2024 | markets.businessinsider.comGenmab A/S (GMAB): One of the Best Affordable Stocks Under $40 According to Short SellersAugust 30, 2024 | insidermonkey.comDecoding 10 Analyst Evaluations For GenmabAugust 20, 2024 | benzinga.comHere's what to expect from Genmab A-S (spons ADRs)'s earningsAugust 7, 2024 | markets.businessinsider.comThe U.S. Army's Latest Main Battle Tank: The AbramsXAugust 5, 2024 | msn.comWhat 8 Analyst Ratings Have To Say About GenmabAugust 1, 2024 | benzinga.comStrong Buy Rating for Genmab’s Stock Backed by FDA Approval and Positive Clinical DataAugust 1, 2024 | markets.businessinsider.comDecoding 9 Analyst Evaluations For GenmabApril 30, 2024 | markets.businessinsider.comMeet the Genesis Electrified G80 Magma: A Sleek and Speedy ConceptApril 28, 2024 | msn.com2026 Genesis GV70 Will Be Updated with a Huge New Screen InsideApril 26, 2024 | msn.comHow an Album From 1977 Became a Gen Z TouchstoneApril 26, 2024 | yahoo.comAs lead gen grows on social media, marketers discuss what’s workingApril 20, 2024 | msn.comWhat will RenCen be used for once GM moves headquarters to Hudson's site?April 17, 2024 | msn.comThe Comics History Behind Genosha, Marvel's Fallen Mutant HavenApril 12, 2024 | yahoo.comGene variant may protect against Alzheimer'sApril 12, 2024 | msn.comGen X only has $108,600 saved for retirement — but they think they'll need $1.45 million more to live comfortably, a survey foundApril 4, 2024 | msn.com'No one can replace him': Internet abuzz as 'Gen V' Season 2 filming delayed indefinitely following Chance Perdomo's deathApril 1, 2024 | msn.comSeoul’s Glimpse into Automotive History with a Vintage BMW AppearanceApril 1, 2024 | msn.comAudacious XM a change of direction for BMW’s M divisionMarch 31, 2024 | msn.comGen Z’s Behavior in the Workplace is Both Toxic and Delusional, Report RevealsMarch 31, 2024 | msn.com32 BMW iX EVs were just inducted into this company's fleetMarch 30, 2024 | msn.com"Gen Alpha Needs A Reality Check": 22 Gen Z'ers Were Brutally Honest About The Difference Between Them And Gen AlphaMarch 29, 2024 | msn.comVisalia’s BMX park flattened by the city: what riders want to happen nextMarch 29, 2024 | msn.comRetirement Planning: Nearly Half of Gen X and Younger Generations Fear Savings Not Enough — 4 Reasons It’s Never Too Late To Catch UpMarch 18, 2024 | msn.comGemini: Your finance horoscope - March 17March 17, 2024 | msn.comBMW's annual automotive margin falls below expectationsMarch 16, 2024 | msn.comMG Excelor EV nameplate trademarked, will be brand's 3rd EV after ZS EV & CometMarch 15, 2024 | msn.comAbu Dhabi Launches MGX: A Global Tech VentureMarch 13, 2024 | msn.comGen Z is reshaping the workforce. Here's how managers can embrace that change.February 22, 2024 | bizjournals.comMany managers have a Gen Z problem. Here's how they can solve it.February 22, 2024 | bizjournals.comFORD EXPLORER ST DRAGS ACURA MDX TYPE S AND GENESIS GV80 WITH SURPRISING RESULTSFebruary 2, 2024 | msn.comGen Zers are balking at the suggestion that a $74,000 salary is considered 'middle class,' with home ownership feeling like a distant dreamJanuary 4, 2024 | msn.comGet early Labor Day savings of up to $830 on the Samsung Galaxy Tab S9August 26, 2023 | usatoday.com Remove Ads Get GENMAB A/S/S News Delivered to You Automatically Sign up to receive the latest news and ratings for GMXAY and its competitors with MarketBeat's FREE daily newsletter. Email Address GMXAY Media Mentions By Week GMXAY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GMXAY News Sentiment▼0.000.69▲Average Medical News Sentiment GMXAY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GMXAY Articles This Week▼00▲GMXAY Articles Average Week Remove Ads Get GENMAB A/S/S News Delivered to You Automatically Sign up to receive the latest news and ratings for GMXAY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Algernon Pharmaceuticals News Allstar Health Brands News Anew Medical News Arno Therapeutics News AstraZeneca News AVAX Technologies News AVVAA World Health Care Products News BriaCell Therapeutics News Cannabis Global News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GMXAY) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMarch 18th: Gold SHOCK? On March 18th, an event is taking place that could completely shock the market. Stocks could go ballistic…...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENMAB A/S/S Please log in to your account or sign up in order to add this asset to your watchlist. Share GENMAB A/S/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
